Document ID: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_04-cv-05429/USCOURTS-cand-4_04-cv-05429-6/pdf.json

Parties Involved:
Celtrix Pharmaceuticals, Inc.
Counter-claimant
Genentech, Inc.
Counter-defendant
Insmed Incorporated
Counter-claimant
Insmed Therapeutic Proteins
Defendant
Tercica, Inc.
Counter-defendant

Document Text:

MCDERMOTT 

WILL & EMERY LLP 

ATTORNEYS AT LAW

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 98869-1.073241.0011 STIPULATION TO FILE

THIRD AMENDED COMPLAINT

CASE NO. C-04-5429 CW (EMC) 

MCDERMOTT WILL & EMERY LLP 

WILLIAM G. GAEDE, III (136184) 

wgaede@mwe.com 

ANDREW A. KUMAMOTO (178541) 

akumamoto@mwe.com 

DAVID L. LARSON (112342) 

dlarson@mwe.com 

3150 Porter Drive 

Palo Alto, CA 94304-1212 

Telephone: (650) 813-5000 

Facsimile: (650) 813-5100 

Attorneys for Tercica, Inc. 

HELLER EHRMAN LLP 

M. PATRICIA THAYER (90818) 

patrica.thayer@hewm.com 

ETHAN C. GLASS (216159) 

ethan.glass@hewm.com 

333 Bush Street 

San Francisco, CA 94104-2878 

Telephone: (415) 772-6000 

Facsimile: (415) 772-6268 

Attorneys for Genentech, Inc 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

OAKLAND DIVISION 

GENENTECH, INC., a Delaware 

Corporation, TERCICA, INC., a Delaware 

Corporation,

Plaintiffs,

 v. 

INSMED INCORPORATED, a Virginia 

Corporation, and CELTRIX 

PHARMACEUTICALS, INC., a Delaware 

Corporation,

Defendants.

No. C-04-5429 CW (EMC) 

STIPULATION AND ORDER TO FILE

THIRD AMENDED COMPLAINT FOR

PATENT INFRINGEMENT AND FOR

DECLARATORY JUDGMENT OF

PATENT INFRINGEMENT 

AND RELATED COUNTERCLAIMS. 

Case 4:04-cv-05429-CW Document 210 Filed 10/13/05 Page 1 of 3
MCDERMOTT 

WILL & EMERY LLP 

ATTORNEYS AT LAW

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 98869-1.073241.0011 1

STIPULATION TO FILE

THIRD AMENDED COMPLAINT 

CASE NO. C-04-5429 CW (EMC) 

IT IS HEREBY STIPULATED, by and between the parties hereto, through their 

respective counsel, that Plaintiffs may file the attached Third Amended Complaint For Patent 

Infringement and For Declaratory Judgment of Patent Infringement. 

IT IS FURTHER STIPULATED, by and between the parties hereto, through their 

respective counsel, that service of Insmed Therapeutic Proteins has been accepted by counsel for 

Defendants and that Insmed Therapeutic Proteins shall be deemed served upon the filing of this 

Stipulation.

IT IS FURTHER STIPULATED that, pursuant to Fed. Civ. R. Proc. 15(a), Defendants’ 

Response to Plaintiffs’ Third Amended Complaint shall be filed no later than 10 days from the 

date of service of the Court’s order granting leave to amend. 

Dated: October 12, 2005 MCDERMOTT WILL & EMERY LLP 

By: /s/ William G. Gaede, III

William G. Gaede, III 

 Attorneys for Tercica, Inc. 

Dated: October 12, 2005 HELLER EHRMAN LLP 

By: /s/ M. Patricia Thayer 

M. Patricia Thayer 

 Attorneys for Genentech, Inc. 

Dated: October 12, 2005 FOLEY & LARDNER LLP 

 By: /s/ Larry L. Shatzer 

Larry L. Shatzer 

 Attorneys for Insmed Incorporated and 

 Celtrix Pharmacuticals, Inc. 

Case 4:04-cv-05429-CW Document 210 Filed 10/13/05 Page 2 of 3
MCDERMOTT 

WILL & EMERY LLP 

ATTORNEYS AT LAW

PALO ALTO

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MPK 98869-1.073241.0011 2

ORDER GRANTING STIPULATION TO FILE

THIRD AMENDED COMPLAINT 

CASE NO. C-04-5429 CW (EMC) 

 IT IS SO ORDERED. 

Dated: By: 

HONORABLE CLAUDIA WILKEN 

United States District Court Judge 

10/13/05

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

IT IS SO ORDERED

Judge Claudia Wilken

Case 4:04-cv-05429-CW Document 210 Filed 10/13/05 Page 3 of 3